HomeAbout UsSubscribeResources & ContentArchives Info for Authors Reprints & Back IssuesContact UsAdvertising

In the News

Cancer Treatment Centers of America at Midwestern Regional Medical Center Recognized for Providing Exceptional Quality Care by American Society of Clinical Oncology

XYMOGEN Ranked Among The Nation's Fastest Growing Private Companies For A Seventh Time




Released: 09/03/14


Cancer Treatment Centers of America at Midwestern Regional Medical Center Recognized for Providing Exceptional Quality Care by American Society of Clinical Oncology

Cancer Treatment Centers of America at Midwestern Regional Medical Center has been recognized by the Quality Oncology Practice Initiative (QOPI) Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO), for meeting the highest standards for quality cancer care.  The QOPI Certification Program (QCP) provides a three-year certification for outpatient hematology-oncology practices that meet the benchmarks.

"We are honored to receive this esteemed certification from ASCO," said Scott Jones, CEO and president of CTCA at Midwestern. "We are dedicated to providing quality care to our patients and we are pleased to be recognized for our commitment."

QOPI is a voluntary, self-assessment and improvement program launched by ASCO in 2006 to help hematology-oncology and medical oncology practices assess the quality of the care they provide to patients. The QCP was launched in January 2010, with more than 200 practices already certified. This is the first program of its kind for oncology in the United States. Oncologists can achieve certification by meeting the highest standards of care.

QOPI analyzes individual practice data and compares these to more than 160 evidence-based and consensus quality measures. The information is then provided in reports to participating practices.  Individual practices are also able to compare their performance to data from other practices across the country. Based on this feedback, doctors and outpatient practices can identify areas for improvement.  

To become certified, practices have to submit an evaluation of their entire practice and documentation standards. The QCP staff and steering group members then verify through on-site inspection that the evaluation and documents are correct and that the practice meets core standards in areas of:

·         Treatment planning

·         Staff training and education

·         Chemotherapy orders and drug preparation

·         Patient consent and education

·         Safe chemotherapy administration

·         Monitoring and assessment of patient well-being

The QCP seal designates those practices that not only scored high on the key QOPI quality measures, but meet rigorous chemotherapy safety standards established by ASCO and the Oncology Nursing Society (ONS). The QOPI Certification Program is a project of ASCO's Institute for Quality, an ASCO affiliate dedicated to innovative quality improvement programs. For more information, please visit qopi.asco.org/certification.html.

CTCA at Midwestern is also a Magnet recognized center for nursing excellence, a designation the hospital earned in 2013. For more information about CTCA, please visit cancercenter.com.

 

SOURCE Cancer Treatment Centers of America

 

Released: 09/03/14


XYMOGEN Ranked Among The Nation's Fastest Growing Private Companies For A Seventh Time

Orlando-based health sciences company XYMOGEN announced today that it has been recognized for the seventh time on Inc. Magazine's Inc. 5000 list as one of the fastest growing and best run private companies in the nation.

Inc. Magazine compiles the annual list based on revenue growth over a three-year period. 

As a seven-time winner, XYMOGEN is part of an exclusive group known as the Honor Roll Alumni, a select circle of businesses to have made the list at least five times. This year also marks the fifth consecutive year that the company has earned a spot in the rankings.

With 27 percent revenue growth in 2013 and more than 200 jobs added since 2009, XYMOGEN is one of very few companies to thrive during a tough economic time. The company credits its growth and momentum to a company culture that focuses on its team of dedicated employees.

"Our success is an authentic reflection of the XYMOGEN family's hard work and commitment to what we do," said CEO Brian Blackburn. "XYMOGEN's success comes from innovative thinking and a customer-focused mentality that our employees work toward every day."

XYMOGEN is known for providing high-quality dietary supplements to licensed health care practitioners and the functional medicine community. The company attributes its strength and reputation to a "People First" culture, which offers employees unprecedented opportunities for professional growth and fulfillment. 

 

 

SOURCE XYMOGEN

 

All contents © Copyright -2014 Alternative Therapies in Health and Medicine. All rights reserved. Alternative Therapies in Health and Medicine is a registered trademark.
All rights reserved. Terms and Conditions.